Stachlewitz RF[au] - Search Results

Year	Number of Results
1995	1
1996	2
1997	6
1998	3
1999	3
2000	3
2005	3
2006	3
2007	1
2014	1
2022	0

1

Nonclinical safety of the sodium-glucose cotransporter 2 inhibitor empagliflozin.

Bogdanffy MS, Stachlewitz RF, van Tongeren S, Knight B, Sharp DE, Ku W, Hart SE, Blanchard K. Bogdanffy MS, et al. Among authors: stachlewitz rf. Int J Toxicol. 2014 Nov-Dec;33(6):436-49. doi: 10.1177/1091581814551648. Epub 2014 Sep 26. Int J Toxicol. 2014. PMID: 25260362

2

Bringing biomarkers to the masses: an elegant approach to discover potential biomarkers of vascular injury.

Stachlewitz RF. Stachlewitz RF. Toxicol Sci. 2007 Nov;100(1):5-6. doi: 10.1093/toxsci/kfm228. Toxicol Sci. 2007. PMID: 18035605 No abstract available.

3

Prevention of cyclosporine-induced nephrotoxicity with dietary glycine.

Thurman RG, Zhong Z, von Frankenberg M, Stachlewitz RF, Bunzendahl H. Thurman RG, et al. Among authors: stachlewitz rf. Transplantation. 1997 Jun 15;63(11):1661-7. doi: 10.1097/00007890-199706150-00021. Transplantation. 1997. PMID: 9197363

4

Kupffer cells contain a glycine-gated chloride channel.

Ikejima K, Qu W, Stachlewitz RF, Thurman RG. Ikejima K, et al. Among authors: stachlewitz rf. Am J Physiol. 1997 Jun;272(6 Pt 1):G1581-6. doi: 10.1152/ajpgi.1997.272.6.G1581. Am J Physiol. 1997. PMID: 9227496

5

Discovery of A-770041, a src-family selective orally active lck inhibitor that prevents organ allograft rejection.

Burchat A, Borhani DW, Calderwood DJ, Hirst GC, Li B, Stachlewitz RF. Burchat A, et al. Among authors: stachlewitz rf. Bioorg Med Chem Lett. 2006 Jan 1;16(1):118-22. doi: 10.1016/j.bmcl.2005.09.039. Epub 2005 Oct 10. Bioorg Med Chem Lett. 2006. PMID: 16216497

6

Modest inflammation enhances diclofenac hepatotoxicity in rats: role of neutrophils and bacterial translocation.

Deng X, Stachlewitz RF, Liguori MJ, Blomme EA, Waring JF, Luyendyk JP, Maddox JF, Ganey PE, Roth RA. Deng X, et al. Among authors: stachlewitz rf. J Pharmacol Exp Ther. 2006 Dec;319(3):1191-9. doi: 10.1124/jpet.106.110247. Epub 2006 Sep 21. J Pharmacol Exp Ther. 2006. PMID: 16990511

7

A-770041, a novel and selective small-molecule inhibitor of Lck, prevents heart allograft rejection.

Stachlewitz RF, Hart MA, Bettencourt B, Kebede T, Schwartz A, Ratnofsky SE, Calderwood DJ, Waegell WO, Hirst GC. Stachlewitz RF, et al. J Pharmacol Exp Ther. 2005 Oct;315(1):36-41. doi: 10.1124/jpet.105.089169. Epub 2005 Jul 12. J Pharmacol Exp Ther. 2005. PMID: 16014572

8

Glycine inhibits growth of T lymphocytes by an IL-2-independent mechanism.

Stachlewitz RF, Li X, Smith S, Bunzendahl H, Graves LM, Thurman RG. Stachlewitz RF, et al. J Immunol. 2000 Jan 1;164(1):176-82. doi: 10.4049/jimmunol.164.1.176. J Immunol. 2000. PMID: 10605009 Free article.

9

Microarray analysis of lipopolysaccharide potentiation of trovafloxacin-induced liver injury in rats suggests a role for proinflammatory chemokines and neutrophils.

Waring JF, Liguori MJ, Luyendyk JP, Maddox JF, Ganey PE, Stachlewitz RF, North C, Blomme EA, Roth RA. Waring JF, et al. Among authors: stachlewitz rf. J Pharmacol Exp Ther. 2006 Mar;316(3):1080-7. doi: 10.1124/jpet.105.096347. Epub 2005 Nov 18. J Pharmacol Exp Ther. 2006. PMID: 16299187

10

Glycine-gated chloride channels in neutrophils attenuate calcium influx and superoxide production.

Wheeler M, Stachlewitz RF, Yamashina S, Ikejima K, Morrow AL, Thurman RG. Wheeler M, et al. Among authors: stachlewitz rf. FASEB J. 2000 Mar;14(3):476-84. doi: 10.1096/fasebj.14.3.476. FASEB J. 2000. PMID: 10698962

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results